Tal Medical is a clinical stage neuroscience company developing non-invasive, at-home neuromodulation treatments for depression and other brain disorders.

Our lead platform is Low Field Magnetic Stimulation (LFMS), a novel, subthreshold form of brain stimulation discovered at McLean Hospital / Harvard University.

Six randomized controlled studies provide proof of concept for LFMS’ rapid antidepressant effect, without any major side effects; a pivotal study is planned.

If this clinical effect is confirmed, LFMS could have a transformative impact on the way we treat depression and potentially other neuropsychiatric disorders.